Sha***.D.

Senior Director Corporate Development

Bildung

Max Planck Institute for Polymer Research

Max Planck Institute for Polymer Research (2013 - 2016)

  • Degree: Doctor of Philosophy (Ph.D.)
  • Field of Study: Chemistry
  • Description: Main focus: Complex Colloids Prepared by Emulsion Techniques For Biomedical applications Thesis Title: “Advanced Polymer Nanocapsules with Enhanced Capabilities for Controlled-Release of Payloads”

Harvard Business School Online (2021 - 2021)

  • Degree: Certificate in Disruptive Strategy
  • Field of Study: Unknown Field
  • Description:

Sharif University of Technology (2009 - 2012)

  • Degree: Master's degree
  • Field of Study: Materials Science and Engineering
  • Description: Main focus: Nanomaterials Fabrication and Characterization Thesis Title: “Synthesis and Biocompatibility Evaluation of Titanium Oxide/Pyrolytic Carbon Core/Shell Nanoparticles”

Fähigkeiten:

Corporate Strategy, Business Development, Research and Development (R&D), Competitive Intelligence

Berufserfahrung:

Senior Director Corporate Development at ReAlta Life Sciences

  • Location: Virginia, United States
  • Duration: 2024-07 to Present
  • Description: ReAlta Life Sciences is a clinical stage company focused on inflammatory diseases. Our platform presents a novel opportunity to modify disease progression through moderation of the most robust components of both humoral (complement system) and cellular (neutrophils) components of innate inflammatory responses

Director of Strategy & Business Development at Ginkgo Bioworks, Inc.

  • Location: Boston, Massachusetts, United States
  • Duration: 2023-07 to 2024-06
  • Description: As a Director of Corporate Strategy & BD, I scout new areas where Ginkgo’s cell therapy platform is ripe to be a disruptive technology and introduce that expertise to prospective pharma / biotech partners. I distill information from prospective partner conversations and secondary sources and advance this thinking into specific deal concepts that meet partner needs and utilize Ginkgo’s capabilities / assets to its fullest potential. As deals progress, I shepherd them closely, but also keep an eye on the big picture and ensure that our team priorities are focused on the best fit and highest likelihood opportunities

Associate Director, Corporate and Business Development at Senda Biosciences

  • Location: Greater Boston
  • Duration: 2022-04 to 2023-07
  • Description: As a Senior Manager and later as an Associate Director of Corporate & Business Development, I excel at creating corporate/BD strategy by actively leading / participating in variety of activities. I frequently generated strategic insights based on best-in-class analysis, and distilled outputs and recommendations which enabled informed decisions of top-level leaders. I have built investor presentations and created corporate messages for Series B and C funding rounds, resulting in ~$225 M investment. To fulfill these activities, I partnered with the Heads of the Corporate, R&D, Translational Medicine, and Finance teams as I led Senda’s Business Intelligence team and managed the “Pipeline Creation” workstream. Regarding BD efforts, I drove several strategic partnership cases for Senda including out-licensing and co-development agreements. In fact, I partnered with the Head of the BD team to map and prioritize external opportunities in emerging areas that address Senda’s portfolio gaps and support value creation.

Senior Manager, Corporate and Business Development at Senda Biosciences (A Flagship Pioneering Company)

  • Location: Greater Boston
  • Duration: 2021-04 to 2022-03
  • Description:

Life Sciences Consultant at ClearView Healthcare Partners

  • Location: Greater Boston Area
  • Duration: 2019-03 to 2021-03
  • Description: As a Life Sciences Consultant at ClearView Healthcare Partners in Boston, I honed my strategic consulting expertise in the life sciences sector. My experience in the life science space ranges from R&D to commercial and marketing strategy. I have enjoyed adding value to several engagements where clients primarily included Fortune 100, mid-cap, and private biotech companies. I performed indication opportunity assessment, extensive due diligence, therapeutic area strategy, and prepared strategic plans to address unmet medical needs across several therapeutic areas including cell & gene therapy, oncology, immunology, CNS, cardiology, etc.
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

The candidate has a continuous work history from 2019 to present with immediate transitions between roles, indicating no reported employment gaps.

Industry ConsistencyLow

All roles are within the life sciences/biotech sector (consulting, strategy/BD, and R&D ecosystem), including biotech startups and large platforms, which shows strong industry consistency.

Tenure StabilityMedium

Most prior roles are around 12 months in duration with a pattern of moving to higher responsibilities; while the current role has extended into multiple years, the past shorter tenures suggest moderate stability risk for long-term tenure.

Education-Career MatchLow

Ph.D. and postdoctoral work in nanoparticle-based drug delivery from premier institutions align well with senior BD/strategy roles in biotech, enhancing credibility and domain expertise.

Karrierewachstumskurve

Life Sciences Consultant Entry
ClearView Healthcare Partners
2019-03 to 2021-03
Senior Manager, Corporate and Business Development ↑ Befördert
Senda Biosciences (Flagship Pioneering)
2021-04 to 2022-03
Associate Director, Corporate and Business Development ↑ Befördert
Senda Biosciences
2022-04 to 2023-07
Director of Strategy & Business Development ↑ Befördert
Ginkgo Bioworks
2023-07 to 2024-06
Senior Director Corporate Development ↑ Befördert
ReAlta Life Sciences
2024-07 to Present
Bewertung:The candidate exhibits a clear upward trajectory with progressively broader responsibility in biotech corporate strategy, BD, and fundraising. The pattern suggests readiness for senior leadership roles (VP/CSO-level) overseeing strategy, alliances, and portfolio development in biotech/pharma.

Bestpassende Rollen (Top 5)

1

Vice President, Corporate Development96% Passung

Proven track record leading corporate/BD strategy, complex partnerships, and fundraising across multiple biotech platforms; strong cross-functional leadership and ability to shape portfolio strategy at scale.

2

Senior Vice President, Strategy & Corporate Development92% Passung

Extensive experience drafting and executing strategic initiatives at the intersection of R&D, translational medicine, and external partnerships; aligns with senior executive expectations for portfolio optimization.

3

Head of Strategic Partnerships90% Passung

Deep experience in partner search/evaluation, co-development/out-licensing, and deal structuring; suitable for a role focused on external collaborations and pipeline strategy.

4

Chief Strategy Officer88% Passung

Capabilities in corporate/portfolio strategy, fundraising narrative, and investor communications; well-suited for leading company-wide strategic direction in a growth-stage biotech.

5

Director/VP, BD & Portfolio Strategy85% Passung

Strong BD and portfolio-building background with cross-functional leadership; could drive early-stage to late-stage value creation in a mid-cap biotech.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit